Worldwide discovery and license agreement with Allergan Inc.
 |  |  |
31.10.2008
Polyphor enters into an exclusive agreement with Allergan to develop PEM cytokine inhibitors for the treatment of ophthalmology.
 | 43 kB |
| | |
31.10.2008
Polyphor enters into an exclusive agreement with Allergan to develop PEM cytokine inhibitors for the treatment of ophthalmology.
| 43 kB |